What is being tested to slow Alzheimer’s disease?
Quick answer: Current disease-modifying drugs can modestly slow decline in some people with early-stage Alzheimer’s; they do not restore lost memory or stop the disease.
Current disease-modifying drugs can modestly slow decline in some people with early-stage Alzheimer’s; they do not restore lost memory or stop the disease.
- Anti-amyloid antibodies aim to reduce a protein linked to Alzheimer’s pathology.
- Brain imaging and other testing help determine who may qualify and monitor important risks.
- Researchers are testing tau-targeted drugs, vaccines, anti-inflammatory strategies, and combinations.
- Trials must show that biological changes translate into meaningful and durable benefits for patients.
Good to know: Ask a memory specialist about diagnosis, eligibility, expected benefit, monitoring, and treatment risks rather than relying on headlines.
Ask AI about this tip
Send this tip to your favorite AI assistant for a plain-language walkthrough, follow-up questions, or help applying it to your device.
Was this helpful?